SLE-目标治疗-协和医院-赵岩.pptxVIP

  • 10
  • 0
  • 约1.94万字
  • 约 64页
  • 2021-11-02 发布于江苏
  • 举报
狼疮:“目标(mùbiāo)治疗” 的曙光?2012 第一页,共64页。CD20(Rituximab): RCT研究(yánjiū) EXPLORER LUNAR BELIEVERS RINGAssessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER).Lupus. 2011 Jun;20(7):709-16. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Arthritis Rheum. 2012 ; 64(4):1215-26.第二页,共64页。EXPLORER研究:首个狼疮治疗研究的RCT目标(mùbiāo)治疗,并以失败告终评价体系:BILAGAssessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER). Lupus. 2011; 20(7):709-16. 第三页,共64页。C

文档评论(0)

1亿VIP精品文档

相关文档